Press release
Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: A Significant Driver Propelling The Biodefense Market In 2025
Biodefense
What Is the Biodefense Market Size and Projected Growth Rate?
The biodefense market has experienced strong growth in recent years. It will grow from $18.55 billion in 2024 to $20.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.4%. This growth is driven by increased government investment in biodefense programs, strengthened regulatory frameworks to expedite product approvals, enhanced collaboration between government, private sector companies, and academic institutions, as well as growing concerns over bioterrorism and geopolitical tensions.
The biodefense market is expected to grow to $28.75 billion by 2029 at a CAGR of 9.1%. Growth drivers include new infectious diseases, biotechnology breakthroughs, and increased global collaboration. Trends include AI use for predictive modeling, next-generation vaccines, and genomic surveillance.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15993
What Are the Major Segments in the Biodefense Market?
The biodefense market covered in this report is segmented -
1) By Type: Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types
2) By Biothreat Detection Device: Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices
3) By Application: Hospitals And Clinics, Ambulatory Care Centers, Other Applications
Subsegments:
1) By Anthrax: Bacillus Anthracis Vaccine, Anthrax Therapeutics
2) By Smallpox: Smallpox Vaccine, Antiviral Drugs For Smallpox
3) By Botulism: Botulism Antitoxin, Botulism Vaccine, Botulinum Neurotoxin Inhibitors
4) By Radiation Or Nuclear: Radiation Protection Drugs, Medical Countermeasures
5) By Other Types: Ricin, Plague, Tularemia, Viral Hemorrhagic Fevers, Other Biotoxins Or Biothreat Agents
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15993&type=smp
What Are The Driving Biodefense Market Evolution?
The recurring threat of emerging infectious diseases is expected to drive the biodefense market. Infectious diseases, caused by pathogens like bacteria and viruses, pose a growing global challenge. Biodefense systems help enhance preparedness and early detection, improving responses to biological threats. The World Health Organization (WHO) reported in November 2023 that tuberculosis (TB) cases reached 10.6 million globally in 2022. As infectious diseases remain a global concern, the biodefense market will continue to grow.
Which Firms Dominate The Biodefense Market Segments?
Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals
What Are the Latest Developing Trends in the Biodefense Market?
Companies in the biodefense market are focusing on developing innovative solutions like nasal COVID-19 vaccines to improve global preparedness against biological threats. Nasal vaccines provide easier administration, potential mucosal immunity, reduce reliance on needles, and improve accessibility. For instance, in January 2023, Bharat Biotech International Limited, a biotechnology company from India, launched the iNCOVACC Nasal COVID-19 vaccine, using a recombinant replication-deficient adenovirus vector. It underwent successful clinical trials and is delivered intranasally via nasal drops, with a two-dose regimen given four weeks apart.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/biodefense-global-market-report
Which Is The Largest Region In The Biodefense Market?
North America was the largest region in the biodefense market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Biodefense Market?
2. What is the CAGR expected in the Biodefense Market?
3. What Are the Key Innovations Transforming the Biodefense Industry?
4. Which Region Is Leading the Biodefense Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: A Significant Driver Propelling The Biodefense Market In 2025 here
News-ID: 4034880 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Biodefense
Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: Transformativ …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Biodefense Industry Market Size Be by 2025?
The biodefense sector has experienced robust expansion lately, projected to increase its market valuation from $18.55 billion in 2024 to $20.23 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.1%. This historical upswing is primarily fueled…
Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: Strengthening …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Biodefense Market Through 2025?
In recent times, there has been significant growth in the biodefense market size. The expansion from $18.55 billion in 2024 to $20.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.4%, can be seen. This…
Biodefense Market 2032
The Biodefense Market focuses on developing, integrating, and applying medical interventions such as drugs and vaccinations to protect against bioterrorism. With increasing global awareness of biological threats, advancements in biotechnological research, and the development of effective countermeasures, this market is experiencing significant growth.
Download Sample Report Copy Of This Report From Here: https://www.amecoresearch.com/sample/276690
Key Points and Statistics:
• Market Size: Projected to reach USD 22,881 Million by 2030, with a CAGR of 5.8%…
Biodefense Market - Enhancing Preparedness, Mitigating Threats: Innovative Biode …
Newark, New Castle, USA - new report, titled Biodefense Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biodefense market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biodefense market. The report offers an overview of the market, which briefly describes the…
Biodefense Treatment Market 2025| Target U.S For Maximum Profitability in Biodef …
Even though the UN has a convention against biological warfare, the threat of bioterrorism is greater than ever. To counter rogue pathogens and non-state actors, countries must beef up their R&D budgets of biodefense treatments. COVID-19 has raised numerous questions about global safety and security. Fairfield Market Research estimates that the biodefense treatment market should grow at an exponential rate for the forecast period ending in 2025.
Get Sample of this…
US Biodefense Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title US Biodefense Market Outlook 2022 to its growing collection of premium market research reports.
The dangers posed by the weapons of mass destruction have caught the attention of every nation worldwide. These weapons can be characterized by their potential for large-scale destruction and the indiscriminate nature of their effects, notably against civilians. Increasing threat of biological, chemical as well as nuclear…
